Marathon Capital Management Amgen Inc Transaction History

Marathon Capital Management

$380 Million
Q2 2024

A detailed history of Marathon Capital Management transactions in Amgen Inc stock. As of the latest transaction made, Marathon Capital Management holds 1,188 shares of AMGN stock, worth $383,331. This represents 0.1% of its overall portfolio holdings.

Number of Shares

1,188

Previous 913 30.12%

Holding current value

$383,331

Previous $259,000 43.24%

% of portfolio

0.1%

Previous 0.06%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $72,256 - $87,810	275 Added 30.12%	1,188 $371,000
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $2,356 - $2,787	11 Added 1.22%	913 $202,000
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $8,016 - $10,185	-35 Reduced 3.74%	902 $236,000
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $216,175 - $240,565	937 New	937 $228,000
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $205,455 - $227,288	-937 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $141,005 - $161,368	-709 Reduced 43.07%	937 $210,000
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $154,108 - $180,556	726 Added 78.91%	1,646 $351,000
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $5,605 - $6,219	24 Added 2.68%	920 $224,000
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $2,441 - $2,844	11 Added 1.24%	896 $222,000
Q4 2020 Feb 08, 2021	SELL	$216.38 - $257.67 $8,655 - $10,306	-40 Reduced 4.32%	885 $203,000
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $14,079 - $15,657	60 Added 6.94%	925 $235,000
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $171,105 - $209,970	865 New	865 $204,000
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $230,533 - $305,750	-1,265 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $35,760 - $45,964	189 Added 17.57%	1,265 $304,000
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $187,342 - $224,475	1,076 New	1,076 $208,000
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $194,616 - $219,374	-1,076 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$178.4 - $208.25 $13,558 - $15,827	76 Added 7.6%	1,076 $209,000
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $185,290 - $208,890	1,000 New	1,000 $207,000

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Capital Management with notifications on news.

Account

Marathon Capital Management Amgen Inc Transaction History